Europe Animal Healthcare Market, By Animal Type (Livestock Animals and Companion Animal), By Route of Administration (Oral, Topical, and Injectable), By Indication (Infectious Disease, Pain, Autoimmune Disease, and Others), and by Country (U.K., Germany,
Description
Europe Animal Healthcare Market, By Animal Type (Livestock Animals and Companion Animal), By Route of Administration (Oral, Topical, and Injectable), By Indication (Infectious Disease, Pain, Autoimmune Disease, and Others), and by Country (U.K., Germany, France, Spain, Russia, Switzerland, Netherlands, Italy, and Rest of Europe) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2028
Animal healthcare include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. Rapid increase in zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive growth of the Europe animal healthcare market.
Market Dynamics
Market players are focused on investments in research and development activities in order to strengthen their market presence in Europe, and to develop novel products to prevent diseases in livestock and pets. For instance, in May 2021, Boehringer Ingelheim collaborated with the Veterinary Oncology Advisory Board (VOAB) comprising experts in veterinary oncology from the U.S., Europe, and Japan to develop therapeutic veterinary solutions. Moreover, in 2018, Boehringer Ingelheim invested US$ 220 million for the development of a production center for veterinary public health in French Rhône-Alpes region, also known as the European vaccine valley.
Companies and their subsidiaries operating in Europe region intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in animals. For instance, in April 2021, Interporc, a Spain-based pork board unveiled a new certified animal welfare seal, IAWS, to endorse good practices that will increase demand for animal healthcare, and drive the market growth.
Key features of the study:
This report provides in-depth analysis of the Europe animal healthcare market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Europe animal healthcare market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc, Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
The Europe animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market
Detailed Segmentation:
Europe Animal Healthcare Market, By Animal Type:
Herbal Extracts
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
Europe Animal Healthcare Market, By Route of Administration:
Memory Enhancement
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
Europe Animal Healthcare Market, By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Europe Animal Healthcare Market, By Country:
U.K.
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Germany
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
France
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Spain
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Russia
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Switzerland
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Netherlands
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Italy
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Rest of Europe
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Company Profiles
Merck & Co., Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Virbac
Dechra Pharmaceuticals Plc
Vetoquinol S.A.
Zoetis Inc.
Ceva Santé Animale
Bayer AG
Elanco
Evonik Industries AG
Archer Daniels Midland Company
“*” marked represents similar segmentation in other categories in the respective section.
Animal healthcare include veterinary and over-the-counter drugs, supplements, nutraceuticals, vaccines, antibiotics and parasiticides, which are used in the treatment of disease associated with digestive system, immunological system, reproductive system, respiratory, and urinary system of animals. Rapid increase in zoonotic viral diseases and other animal-borne diseases can have adverse effects on farming and other occupation. Efficient animal healthcare can facilitate enhanced productivity of livestock to the farmers, as livestock animals provide major protein source through meat and milk. Increasing public-private collaboration to increase awareness about efficient animal healthcare in Europe is expected to drive growth of the Europe animal healthcare market.
Market Dynamics
Market players are focused on investments in research and development activities in order to strengthen their market presence in Europe, and to develop novel products to prevent diseases in livestock and pets. For instance, in May 2021, Boehringer Ingelheim collaborated with the Veterinary Oncology Advisory Board (VOAB) comprising experts in veterinary oncology from the U.S., Europe, and Japan to develop therapeutic veterinary solutions. Moreover, in 2018, Boehringer Ingelheim invested US$ 220 million for the development of a production center for veterinary public health in French Rhône-Alpes region, also known as the European vaccine valley.
Companies and their subsidiaries operating in Europe region intend to leverage their proprietary technologies for the development of novel therapeutics to treat serious medical conditions in animals. For instance, in April 2021, Interporc, a Spain-based pork board unveiled a new certified animal welfare seal, IAWS, to endorse good practices that will increase demand for animal healthcare, and drive the market growth.
Key features of the study:
This report provides in-depth analysis of the Europe animal healthcare market, and provides market size (US$ Mn) and compound annual growth rate (CAGR%) for the forecast period (2022-2028), considering 2021 as the base year
It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
This study also provides key insights about market drivers, restraints, opportunities, new drug launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
It profiles key players in the Europe animal healthcare market based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
Key companies covered as a part of this study include Merck & Co., Inc., Virbac, Dechra Pharmaceuticals Plc, Vetoquinol S.A., Zoetis Inc., Ceva Santé Animale, Bayer AG, Elanco, Evonik Industries AG, and Archer Daniels Midland Company
Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future drug launches, drug class up-gradation, market expansion, and marketing tactics
The Europe animal healthcare market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the Europe animal healthcare market
Detailed Segmentation:
Europe Animal Healthcare Market, By Animal Type:
Herbal Extracts
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
Europe Animal Healthcare Market, By Route of Administration:
Memory Enhancement
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
Europe Animal Healthcare Market, By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Europe Animal Healthcare Market, By Country:
U.K.
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Germany
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
France
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Spain
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Russia
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Switzerland
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Netherlands
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Italy
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Rest of Europe
By Animal Type:
Livestock Animals
Bovine
Porcine
Poultry
Others
Companion Animals
Canine
Feline
Equine
By Route of Administration:
Oral
Topical
Injectable
Subcutaneous Injections
Intramuscular Injections
Intravenous Injections
Intra-peritoneal Injections
Others
By Indication:
Infectious Disease
Pain
Autoimmune Disease
Others
Company Profiles
Merck & Co., Inc.*
Company Overview
Product Portfolio
Financial Performance
Key Highlights
Market Strategies
Virbac
Dechra Pharmaceuticals Plc
Vetoquinol S.A.
Zoetis Inc.
Ceva Santé Animale
Bayer AG
Elanco
Evonik Industries AG
Archer Daniels Midland Company
“*” marked represents similar segmentation in other categories in the respective section.
Table of Contents
195 Pages
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snippet, By Animal Type
- Market Snippet, By Route of Administration
- Market Snippet, By Indication
- Market Snippet, By Country
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market trends
- Partnership, Agreement, and Collaboration Scenario
- Product Launches and Approvals
- Regulatory Scenario
- PEST Analysis
- 4. Europe Animal Healthcare Market – Impact of Coronavirus (Covid-19) Pandemic
- COVID-19 Market Scenario
- Demand Supply of Animal Healthcare Products
- 5. Europe Animal Healthcare Market, By Animal Type, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Livestock Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Bovine
- Porcine
- Poultry
- Others
- Companion Animals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Canine
- Feline
- Equine
- 6. Europe Animal Healthcare Market, By Route of Administration, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Oral
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Topical
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Injectable
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Subcutaneous Injections
- Intramuscular Injections
- Intravenous Injections
- Intra-peritoneal Injections
- Others
- 7. Europe Animal Healthcare Market, By Indication, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, 2017 - 2028
- Segment Trends
- Infectious Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Pain
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Autoimmune Disease
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- Others
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2017 - 2028, (US$ Mn)
- 8. Europe Animal Healthcare Market, By Country, 2017 - 2028, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2022 and 2028 (%)
- Y-o-Y Growth Analysis, For Country, 2017 - 2028
- U.K.
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Germany
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- France
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Spain
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Russia
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Switzerland
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Netherlands
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Italy
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- Rest of Europe
- Market Size and Forecast, By Animal Type, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Route of Administration, 2017 - 2028, (US$ Mn)
- Market Size and Forecast, By Indication, 2017 - 2028, (US$ Mn)
- 9. Competitive Landscape
- Heat Map Analysis
- Market Share Analysis
- Merck & Co., Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Virbac
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Dechra Pharmaceuticals Plc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Vetoquinol S.A.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Zoetis Inc.
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Ceva Santé Animale
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Bayer AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Elanco
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Evonik Industries AG
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Market Strategies
- Archer Daniels Midland Company
- Company Overview
- Product Type Portfolio
- Financial Overview
- Key Highlights
- Analyst Views
- 10. Section
- Research Methodology
- About us and Sales Contact
- *Browse 38 market data tables and 27 figures on "Europe Animal Healthcare Market” - forecast to 2028
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
